MedTrace Logo

A Retrospective Study to Identify New "Omics" Biomarkers of Chronic/Persistent Low Back Pain

NCT02037789 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-09-26

No results posted yet for this study

Summary

Low back pain (LBP) is one of the most common medical problems encountered in daily life; it is related to disability and work absence and accounts for high economical costs in Western societies.

Low-back pain is a diverse group of mixed pain syndromes (neuropathic and nociceptive) with different molecular pathologies at different structural levels displaying similar clinical manifestations. Currently, there are limited biomarkers (mostly imaging) or clinical findings that can be used objectively to help the physician in precise anatomic diagnosis leading to the safest and most cost-effective treatment for the patient (reduction of direct and indirect costs and improvement of treatment efficacy).

The main aim of this trial is to identify all "omics biomarkers" associated with susceptibility to chronic/persistent LBP and its different pathophysiology.

Conditions

  • Persistent/Chronic Low Back Pain

Sponsors & Collaborators

  • GENOS

    collaborator OTHER

  • Ip Research Consulting Sasu

    collaborator INDUSTRY

  • Helmholtz Zentrum München

    collaborator INDUSTRY

  • YURII AULCHENKO

    collaborator UNKNOWN

  • King's College London

    collaborator OTHER

  • University of Parma

    lead OTHER

Principal Investigators

  • MASSIMO ALLEGRI, MD · Fondazione IRCCS Policlinico San Matteo di Pavia

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • United States
  • Australia
  • Belgium
  • Croatia
  • Italy

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02037789 on ClinicalTrials.gov